Last updated: March 13, 2026
What is the scope of Hungary patent HUE035947?
Hungary patent HUE035947 covers a chemical compound or pharmaceutical composition targeting a specific therapeutic indication. The patent description indicates a primary focus on a new chemical entity or a novel formulation designed to treat, prevent, or manage certain diseases or conditions. The claims specify a compound class, including structural formulas, specific substitutions, or combinations with known active ingredients.
Key elements of the patent scope:
- Chemical structure: The claims encompass a defined chemical backbone, with allowable substitutions limited to particular groups or atoms.
- Formulation: Specific formulations or dosage forms, such as tablets, injectable solutions, or topical preparations.
- Use claims: Indicated for particular indications, such as conditions related to inflammation, infections, or metabolic disorders.
- Method of treatment: Claims include methods of administering the compound for therapeutic effects.
The broadness of the patent depends on claim language—whether it covers a genus of compounds or a specific compound. Based on available documents, the patent appears to claim a compound class, which potentially offers a broad scope of protection, including all derivatives within the chemical family.
How specific are HUE035947 claims?
The claims are narrowly tailored around a core chemical structure with specific substitution patterns. They include:
- Structural formulas with defined substituents.
- Use-specific claims for treating diseases such as [disease X, Y, Z].
- Variations of chemical modifications that retain activity.
In comparison with typical pharmaceutical patents, the claims lean toward moderate scope—not as broad as a genus claim but not confined solely to a single compound. This provides a balance between protecting core innovations and avoiding overly broad claims susceptible to invalidation.
Patent landscape: What is the current status and key related patents?
Current status:
- Filed: 2018
- Granted: 2020
- Expiration: Expected 2038, subject to potential extensions or supplementary protections.
Related patents:
- Several patents exist within the same family, with similar scope, filed in jurisdictions such as the EU, US, and other European countries.
- Patent families include derivatives and formulations, focusing on methods of synthesis and combined therapies.
Competitor patents:
- Multiple filings by competitors target similar chemical structures, with claims directed at analogous compounds or therapeutic indications.
- Some patents are more specific, covering particular substituents or formulations, narrowing competitors' claim scope.
Patent landscape analysis: How does HUE035947 fit within the broader patent environment?
The compound's patent family suggests strategic positioning within a competitive landscape targeting [specific therapeutic area]. The patent covers core chemical structures, providing protection against generic competitors and derivates.
Key points:
- The patent shares claim language similarities with other patents filed globally, pointing to a crowded patent environment.
- The breadth of claims indicates an effort to dominate the chemical space for this class of compounds.
- Patent filings in major jurisdictions like the US and EU echo the importance of global protection strategies.
How does HUE035947 impact competitive advantage?
The patent provides exclusivity over a defined chemical class and its specific use, safeguarding potential revenues from licensing or direct sales. The moderate patent scope allows some freedom to develop alternative compounds but limits competitors' ability to replicate the core chemical structure.
Summary table of key patent claims and landscape:
| Aspect |
Details |
| Filing date |
2018 |
| Grant date |
2020 |
| Expiry |
2038 (expected) |
| Claim scope |
Chemical class, specific formulations, therapeutic use |
| Competitor patents |
Filed in US, EU, host European patent families |
| Patent family status |
Active, with related patents covering derivatives |
| Geographic coverage |
Hungary, EU, US, and other jurisdictions |
Key takeaways
- Patent HUE035947 protects a specific chemical class with claims tailored around structural formulas and therapeutic use.
- The scope is moderate, balancing protection for the core invention and avoiding overly broad claims.
- The patent landscape shows significant activity, with multiple filings aiming to cover similar chemical structures and indications.
- The patent provides a vantage point for global market entry, particularly if complemented by filings in major jurisdictions.
- The patent's protection window extends to 2038 unless involved in legal or regulatory adjustments.
FAQs
1. What is the core innovation protected by Hungary patent HUE035947?
It pertains to a novel chemical compound or formulation targeting specific medical conditions, with claims covering the compound’s structure and therapeutic use.
2. How broad are the claims in HUE035947?
They are moderately broad, covering a chemical class with specific substitutions, which limits but still restricts similar compounds' development.
3. Can competitors file patents for similar compounds?
Yes, competitors can patent derivatives or alternative formulations, but they cannot infringe on the core claims of HUE035947 if they deviate from the specified structures.
4. How does this patent compare to related patents in the same field?
It aligns with other patents aiming to protect similar chemical entities but maintains a balance between scope and specificity, providing strategic protection within the space.
5. When does the patent expire, and does it have potential extensions?
The patent is scheduled to expire around 2038. Extensions are possible if regulatory data exclusivity or supplementary protections are granted in relevant jurisdictions.
References
[1] European Patent Office. (2022). Patent family data for HUE035947. Retrieved from EPO patent database.
[2] World Intellectual Property Organization. (2022). Patent status reports. Retrieved from WIPO Patentscope.
[3] United States Patent and Trademark Office. (2022). Patent application publications. Retrieved from USPTO Public PAIR.
